Dacula, Al-alshrie D.

HRN: 28-47-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2026
CEFUROXIME 750MG (VIAL)
01/27/2026
02/03/2026
IV
750mg
Q8H
POTT'S DISEASE
Checking Initial Appropriateness 
01/28/2026
CEFTRIAXONE 1G (VIAL)
01/28/2026
02/04/2026
IV
1g
Q12
UTI
Checking Initial Appropriateness 
02/03/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/03/2026
02/10/2026
IV
1.5g
Q6h
Pott’s Disease
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: